Antifungal & Antiprotozoal Pharmacology
Antifungal & Antiprotozoal Pharmacology
Primaquine acts against malaria by disrupting the mitochondria within the parasites, specifically targeting the gametocytes, which in turn prevents replication and the transmission stages of the parasite lifecycle . This mechanism is crucial because it ensures the elimination of gametocytes, effectively reducing the spread and recurrence of malaria .
When an infant is receiving topical antifungal treatment, it is crucial to advise against using occlusive dressings over the treatment area, to ensure adequate air flow and prevent exacerbating the infection. The area should be kept free from occlusive dressings to allow proper healing and avoid the entrapment of moisture that can further promote fungal growth .
Miconazole is selected for treating vaginal yeast infections due to its effective action as an azole antifungal, which inhibits fungal growth by preventing ergosterol synthesis, thereby compromising the fungal cell membrane . It is appropriate for patients showing symptoms such as pruritus and thick, cheesy vaginal discharge, where local application directly addresses the infection site, provides relief, and limits systemic exposure and side effects .
The visual impairment in a patient taking chloroquine is likely due to an adverse effect of the medication, potentially retinal toxicity or other ocular side effects from prolonged use . Rapid detection of these side effects is vital to prevent irreversible damage and to take appropriate regulatory action, thereby ensuring the safety and effectiveness of the ongoing treatment .
In selecting antifungal treatment for a pregnant woman, safety profiles, fetal risk, and treatment efficacy must be considered. Amphotericin B is recommended because, despite its potential side effects, it is less teratogenic compared to azoles and can effectively treat serious fungal infections without significant risk to the fetus . The drug's history of use in pregnancy without congenital anomalies underlines its recommendation despite the need for close monitoring .
Long-term itraconazole therapy may lead to central obesity due to the excess fat deposits in visceral areas being supplied by the portal blood system, which releases fatty deposits into the bloodstream . This redistribution of body fat can result in visible changes in body shape and composition, such as central obesity .
Cryptosporidiosis is primarily characterized by watery diarrhea, stomach cramps, or pain, and may lead to significant dehydration if untreated . Amoebic dysentery, caused by Entamoeba histolytica, involves symptoms like fever, chills, diarrahea, abdominal pain, and stools with blood or mucus . Malaria symptoms are nonspecific but can include fever, headache, malaise, and muscle aches. Tumor necrosis factor and free oxygen radicals involved in malaria can lead to tissue damage in the liver, pancreas, and intestine, resulting in diarrhea and intestinal bleeding . Toxoplasmosis may present cervical lymphadenopathy with generally nontender nodes, along with fever, malaise, night sweats, and myalgias, and it can also include a sore throat .
Azole antifungals, particularly imidazoles, are effective against superficial mycoses. Echinocandins, such as caspofungin, have good tissue penetration with low CSF levels due to low oral bioavailability and are administered intravenously . Allylamines, including naftifine and terbinafine, work by inhibiting ergosterol biosynthesis at the squalene epoxidase level, while morpholines like amorolfine act later in the biosynthetic pathway . Antimetabolite antifungal drugs, exemplified by 5-fluorocytosine, inhibit both DNA and RNA synthesis through conversion to 5-fluorouracil within fungal cells, preventing replication and transcription .
To mitigate gastrointestinal side effects from antimalarial medications, a nurse might recommend taking the drug immediately after meals, to reduce stomach irritation and enhance the medication's tolerance . Adding more, smaller meals throughout the day can also help by minimizing the digestive tract's exposure to high drug concentrations at once, thus promoting better nutrient absorption and overall nutrition .
Before administering antifungal therapy, essential factors include obtaining a confirmed diagnosis to accurately target the infection and avoid adverse effects or unnecessary exposure to antifungal drugs . The reason for a confirmed diagnosis is to ensure the treatment is appropriate for the specific fungal pathogen involved and to reduce the risk of either resistance development or unwarranted side effects from the therapy .